Met-enkephalin, leu-enkephalin, beta-endorphin, dynorphin, and proenkephalin all enhanced natural killer cell and macrophage cytotoxic activity when injected into mice.
All 5 peptides boost immunityEvery tested opioid peptide enhanced both NK cell and macrophage cytotoxic activity
What the researchers found
All five tested opioid peptides enhanced both NK cell and macrophage/monocyte cytotoxic activity when administered by single IP injection in mice.
Why it matters
The finding that all major opioid peptide families enhance tumor-fighting immune cells supports the link between endorphin levels and cancer surveillance.
How the study worked
Mice received single IP injections of met-enkephalin, leu-enkephalin, proenkephalin, dynorphin-(1-17), or beta-endorphin. NK cell and macrophage cytotoxicity were measured by 51Cr release assay.
What this study cannot tell us
Animal study with acute single-injection protocol. Doses and mechanisms not detailed. Chronic effects may differ from acute.
How to read the evidence
Moderate animal evidence with comprehensive testing of multiple peptides against multiple immune cell types.
When this study was published
Published in 1997, contributing to the evidence that opioid peptides broadly enhance innate immune function.
The bigger picture
This comprehensive study strengthened the evidence that the opioid peptide system is a major regulator of innate anti-tumor immunity.
Questions still open
- Do different opioid peptides enhance immune function through the same receptor mechanism?
- Could opioid peptide-based immunotherapy enhance cancer treatment?
Common questions
How do opioid peptides boost the immune system?
Does this mean exercise helps fight cancer?
Read the original research
Effect of enkephalins and endorphins on cytotoxic activity of natural killer cells and macrophages/monocytes in mice.
European journal of pharmacology, 326(2-3), 251-5
Citation
Kowalski, J. (1997). Effect of enkephalins and endorphins on cytotoxic activity of natural killer cells and macrophages/monocytes in mice.. European journal of pharmacology, 326(2-3), 251-5.